SCHEMBL8766679

SCHEMBL8766679

CCOP(=O)(CN(CCCc1ccccc1)c1cc(C(C)(C)C)c(OC)c(C(C)(C)C)c1)OCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 5/20 0.38
LPAR1 Q92633 1/20 0.36
LMNA P02545 2/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CHRM2 P08172 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
CHRM1 P11229 1/20 0.35
DRD1 P21728 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
ADRA1A P35348 1/20 0.35
OPRM1 P35372 1/20 0.35
DRD3 P35462 1/20 0.35
SLC6A3 Q01959 1/20 0.35
KCNH2 Q12809 1/20 0.35
RAF1 P04049 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7119208 0.88 HMGCR (0.43) FDPSLMNACHRM2HTR1AADRA2A
SCHEMBL8766155 0.87 HMGCR (0.42) FDPSLPAR1LMNARAF1MAP2K1
SCHEMBL8766041 0.86 FDPS (0.42) FDPSLPAR1LMNAHTTSMN1; SMN2
SCHEMBL8766494 0.83 HMGCR (0.44) FDPSLMNAHTTSMN1; SMN2OPRM1
SCHEMBL8766488 0.79 MEN1 (0.43) FDPSLPAR1LMNARAF1MAP2K1
SCHEMBL8766532 0.74 HMGCR (0.45) FDPSLPAR1LMNASIGMAR1KDM4E
SCHEMBL8766578 0.74 HMGCR (0.44) LMNAHTTSMN1; SMN2ADRA2ASLC6A2
SCHEMBL8766047 0.74 GAA (0.46) FDPSLMNAHTTSMN1; SMN2CHRM2
SCHEMBL8766658 0.73 MEN1 (0.46) FDPSLMNASIGMAR1KDM4EMEN1
SCHEMBL8766577 0.72 HTR2A (0.46) LMNAHTTSMN1; SMN2L3MBTL1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0559079-B1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR SA (CH) 1997-08-13 EP claimed
EP-0559079-A1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR S.A. (CH) 1993-09-08 EP claimed
EP-0559079-B1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR SA (CH) 1997-08-13 EP disclosed
US-5424303-A For treating hypercholesterolemia and hyperlipidemia SYMPHAR SA (CH) 1995-06-13 US disclosed
EP-0559079-A1 Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them SYMPHAR S.A. (CH) 1993-09-08 EP disclosed